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ABSTRACT
Automated telecommunication interventions, including short message
service and interactive voice response, are increasingly being used to
promote adherence to medications prescribed for cardio-metabolic
conditions. This systematic review aimed to comprehensively assess the
effectiveness of such interventions to support medication adherence,
and to identify the behaviour change techniques (BCTs) and other
intervention characteristics that are positively associated with greater
intervention effectiveness. Meta-analysis of 17 randomised controlled
trials showed a small but statistically significant effect on medication
adherence, OR = 1.89, 95% CI [1.51, 2.36], I2 = 89%, N = 25,101.
Multivariable meta-regression analysis including eight BCTs explained
88% of the observed variance in effect size (ES). The BCTs ‘tailored’ and
‘information about health consequences’ were positively and
significantly associated with ES. Future studies could explore whether
the inclusion of these and/or additional techniques (e.g.,
‘implementation intentions’) would increase the effect of automated
telecommunication interventions, using rigorous designs and objective
outcome measures.
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Introduction
Cardio-metabolic conditions (i.e., having a diagnosis of two, or more, of diabetes mellitus, stroke,
myocardial infraction) are a major public health challenge, and the mortality risk is increasing signifi-
cantly in people over 60 years old (Di Angelantonio et al., 2015; Fuller, Stevens, & Wang, 2001; Nathan,
Meigs, & Singer, 1997). Medication adherence is an important component in both prevention (e.g.,
statins to lower cholesterol in people without prior cardiovascular conditions) and treatment (e.g.,
anti-hypertensives to reduce the risk of stroke among stroke survivors; glucose lowering medication
for type 2 diabetes) of cardio-metabolic health conditions, and is recommended as an essential part
of self-management services (National Institute for Health and Care Excellence [NICE], 2014). Given
the growing prevalence of cardio-metabolic conditions, and the ageing population (NCD Risk
Factor Collaboration, 2016), it is likely that there will be an increase in demand for healthcare
resources to support medication adherence (Tinetti, Fried, & Boyd, 2012). It is also likely that such
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patients will be prescribed more complex medication regimens, in comparison to those with a single
condition, and thus, they will require more regular consultations or other ongoing support.
Although medication is an important component of recommended treatment and prevention
strategies, a substantial proportion of patients do not adhere to their prescribed medication regimens
(Chowdhury et al., 2013; WHO, 2003). Non-adherence is defined as discontinuing medication or
taking less than the prescribed daily dose. Medication non-adherence reduces the effectiveness of
treatment, wastes healthcare resources, and leads to additional consultations, referrals, investi-
gations, prescriptions, and hospital admissions. In England alone, it has been estimated that an
increase in adherence to blood pressure medication would result in saving just over £100 million
per year (York Health Economics Consortium & School of Pharmacy, University of London, 2010).
However, current methods to increase adherence are complex and ineffective (Nieuwlaat et al.,
2014). Thus, there is a need for the development and evaluation of novel interventions to improve
adherence (Department of Health, 2012; NICE, 2009).
Automated telecommunication systems, including voice messaging (IVR: interactive voice
response) and text messaging (SMS: short message service), are one way to deliver health care on
an ongoing basis and as an adjunct to primary and secondary care consultations. Several systematic
reviews suggest that such platforms are inexpensive, acceptable, and promising ways to deliver inter-
ventions for health behaviour change (De Jongh, Gurol-Urganci, Vodopivec-Jamsek, Car, & Atun,
2012; Orr & King, 2015), including adherence to different types of medication (Mistry et al., 2015;
Park, Howie-Esquivel, & Dracup, 2014; Thakkar et al., 2016; Vervloet, Linn et al., 2012). However,
none of these reviews provided evidence on the effectiveness of IVR and SMS interventions to
increase adherence in patients with, or at risk of, cardio-metabolic conditions; and none tried to ident-
ify the active intervention components associated with their effectiveness. For example, previous
reviews combined interventions that used different delivery modes and content, making the identi-
fication of the effective and replicable components of the IVR and SMS delivered interventions
impossible. To address this gap, the aim of this review was to conduct a comprehensive effect-size
(ES) analysis of IVR and SMS interventions to promote adherence to cardio-metabolic medication,
to identify components of these interventions that are associated with their effectiveness, and to
discuss possible mechanisms of action.
To identify the effective intervention components, the present review had three secondary
aims. First, it examined whether the delivery format of the intervention messages (i.e., text or
voice) was associated with intervention effectiveness. To facilitate the translation of such interven-
tions into clinical practice, the review also examined whether the presence of an additional deliv-
ery mode (e.g., face-to-face, booklet) was associated with intervention effectiveness. Second, other
intervention characteristics such as the intervention duration and the frequency and direction of
intervention messages, may be associated with intervention effectiveness (Thakkar et al., 2016).
The identification of such characteristics could have implications for the design of future
interventions.
Third, the active and modifiable intervention content has been systematically categorised by
the taxonomy of behaviour change techniques (BCTs), and associated with intervention effective-
ness (Michie et al., 2013). Evidence suggests that several aspects of BCTs are associated with inter-
vention effectiveness. These are (a) the number of BCTs (Michie, Jochelson, Markham, & Bridle,
2009); and (b) the presence or absence of a single BCT, or of a combination of BCTs (Michie
et al., 2013). Currently, the BCTs that are most effective in promoting medication adherence are
largely unknown.
Methods
Systematic literature review searches were conducted in multiple databases. A random effects model
was used to meta-analyse the effectiveness of the interventions, and meta-regressions were
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conducted to identify the BCTs and the other intervention characteristics that were associated with
intervention effectiveness. This review was not registered.
Selection criteria
Population
Adults aged 18 years and over, who were prescribed oral medication (e.g., anti-hypertensive, anti-gly-
caemic, statins) to treat or prevent cardio-metabolic conditions were included. Adults whose main
prescription was insulin to manage type 1 diabetes mellitus were excluded.
Intervention
Studies where medication adherence was the main focus of the intervention, and where IVR and/or
SMS were the main delivery mode of the intervention, were included. Studies where IVR and/or SMS
were adopted to facilitate communication of clinical outcomes between the patient and the health-
care provider (e.g., to support blood glucose self-monitoring), but delivered no messages to promote
adherence to medication, were excluded.
Design and comparator
Randomised controlled trials (RCTs) with randomisation at the individual patient or cluster (e.g.,
general practice) level were included. Studies in which the intervention was compared with usual
care or a minimal intervention were included. In the latter case, the minimal intervention could be
delivered by IVR and/or SMS (e.g., appointment reminders, screen for symptoms), but studies were
included only if neither of these modes were used to deliver medication adherence messages in
the comparator condition.
Outcome
Medication adherence measured by self-report questionnaires, electronic monitoring devices, pill
counts, or electronic pharmacy records.
Search methods for identification of studies
Studies were identified through the following databases: Medline, Embase, CINAHL, PsycINFO (from
January 1992 to April 2016), and Cochrane Central Register of Controlled Trials (CENTRAL). A sensitive
search strategy was developed using terms for (a) medication adherence, (b) adults with a diagnosis
of, or at risk of, a cardio-metabolic condition (e.g., myocardial infarction, type 2 diabetes mellitus,
stroke), (c) intervention delivery mode (IVR, SMS), and (d) study design (see Appendix 1). Only
studies published in English were included. Results were imported into the reference management
software Endnote, duplicates were removed, and the remaining papers were screened by title and
abstract.
Abstracts were screened and assessed based on the following criteria: whether they reported
information relevant to the targeted (a) behaviour, (b) type of medication, (c) intervention delivery
mode, and (d) study design. Abstracts that did not meet all the criteria were excluded from full
text screening. Full text articles were examined and included if they met all the following criteria:
the article clearly (a) stated that the intervention targeted adults taking medications with the aim
to prevent (e.g., type 2 diabetes mellitus), or treat (e.g., acute coronary syndrome), a cardio-meta-
bolic health condition; (b) described the use of IVR and/or SMS, or multiple modes, to deliver the
intervention (e.g., voice messages with a booklet or with face-to-face appointments), but the IVR
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and/or SMS was considered to be the main delivery mode of the intervention; (c) reported that
patients (or clusters of patients) were randomised; and (d) included at least one medication adher-
ence outcome.
References from review papers (Cutrona et al., 2010; Fjeldsoe, Marshall, & Miller, 2009; Kripalani,
Yao, & Haynes, 2007; Mistry et al., 2015; Park, Howie-Esquivel, & Dracup, 2014; Thakkar et al., 2016;
Vervloet, Linn et al., 2012) and original studies were screened for relevant papers; forward and back-
ward citation searches for relevant papers were conducted; and primary authors were contacted by
email for missing information and/or intervention protocols. S. S. drafted the search strategy. A. K.
developed the search strategy, searched the databases, and screened titles, abstracts, and full text
against the inclusion and exclusion criteria. During this process, S. S. made comments and queries
to A. K.’s notes. Disagreements were resolved through discussion.
Data extraction
A data extraction form was developed and used to extract data from eligible studies. The form con-
tained information on the following: authors, long-term health conditions, recruitment setting (where
participants were identified and how they were approached), characteristics of eligible and analysed
participants, country, delivery mode, intervention characteristics (e.g., duration of the study; message
frequency, duration, and language), and outcome data.
For the medication adherence outcomes, the following information was extracted: (a) the behav-
ioural outcome assessed: taking and/or collecting medication; (b) the definition of the outcome
measured: medications not taken, medications taken, days medication was available to participants;
(c) the method used to collect each outcome: standardised self-report scales, non-standardised self-
report scales with single or multiple items, pill counts, real time medication monitoring devices, elec-
tronic pharmacy records; (d) the type of medication measured (e.g., antiplatelets, statins, pravastatin,
ACE inhibitors, metformin); (e) the time measurements were collected: at baseline and at follow-up;
and (f) the statistical method used: unadjusted or adjusted means (M ) and standard deviation (SD),
percentage or number of participants who provided outcome data. Medication adherence was
defined as taking at least 80% of the prescribed tablets and/or having medications dispensed for
at least 95% days of a prescribed period (Ball, 1974; Sackett & Haynes, 1976).
The methodological quality of the included studies was assessed using the Cochrane risk of bias
tool (Higgins, Thompson, Deeks, & Altman, 2003). Each study was given a score of high, low, or
unclear risk of bias on the seven assessment criteria. However, because it is impossible to blind par-
ticipants to these interventions, studies that were at high risk of bias on any criterion other than blind-
ing of participants and personnel were considered to have high risk of bias.
Intervention coding
The BCTs were coded using the BCT taxonomy (v1) (Michie et al., 2013). Each technique was coded as
‘yes’ or ‘no’, based on whether or not it was described in each intervention. Authors of included
studies were contacted to request missing information about the techniques reported in the papers.
The BCTs delivered through IVR and/or SMS interventions only were coded. The BCTs delivered to
the comparator group, usually referred as ‘usual care’, could not be coded due to lack of reported
information. If studies reported that the intervention group received information relevant to medi-
cation adherence using another delivery mode (e.g., letter) that the comparator group did not
receive, then this was coded as ‘additional delivery mode’. If the intervention messages used the par-
ticipant’s first name, they were coded as ‘personalised’; and if interventions delivered different mess-
ages to different participants, depending on information gained about them, they were coded as
‘tailored’.
One more technique was coded, because it was considered to be potentially important for
changing behaviour: ‘reporting whether or not the behaviour was performed’. This technique
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refers to asking a person to report whether he/she has performed a behaviour (e.g., in a voice or
text message query), without the person monitoring or recording the behaviour. It therefore
differs from the BCT ‘self-monitoring of behaviour’, which refers to monitoring and recording a
behaviour (e.g., in a diary or on a pedometer steps sheet). Our decision to include this additional
technique was based partly on evidence suggesting that self-reports of behaviour may have a
reactive effect on behavioural outcomes (French & Sutton, 2010). More information about the
rules used to code BCTs as well as the BCTs coded for each study can be found in Appendix
2. In addition, interventions were coded in terms of intervention duration (short term: less than
6 months; long term: 6 months or more), message frequency (more frequent: daily; less frequent:
weekly or monthly), and direction of communication (one-way: when participants could not
respond to intervention messages; two-way: when participants could respond to intervention
messages).
The two reviewers independently conducted data extraction, intervention coding, and risk of bias
assessment, for all the included papers. Any disagreements were resolved through discussion.
Data synthesis and statistical analysis
To ensure independence of outcome data in the meta-analysis, the following criteria were developed:
(a) when more than one medication adherence outcome was reported, the one that the reviewers
judged to be more valid was selected (e.g., electronic pharmacy records or electronic monitoring
device, instead of self-reported questionnaire). However, when medication adherence behaviour
was measured by more than one objective measurement (e.g., electronic monitoring device and elec-
tronic pharmacy records), the measurement assessing medication taking instead of collecting medi-
cation was selected; (b) when more than one type of medication was assessed, the one that was
described as the primary target of the intervention was selected. However, when authors did not
explicitly report the primary target of the intervention, the medication that was most comparable
to those used in the other included studies was selected (e.g., Park, Howie-Esquivel, Chung, et al.,
2014; statins instead of antiplatelets). Each study contributed one ES for medication adherence to
the meta-analysis (see supplementary material 1).
To calculate the ES, we used the unadjusted values at the end of the intervention. For continuous
data we selected means (M), standard deviations (SD), and sample sizes. When the standard error was
reported instead of the SD, we calculated the SD manually. For dichotomous data, we used the
number of adherent patients and total sample size in each of the intervention and comparator
groups. The ES was reported as an odds ratio (OR). ESs for continuous data were converted to ORs
and 95% confidence intervals (CI), so that the studies could be compared. To estimate the effect
of the BCTs on the ES, only the (eight) BCTs that were coded in at least three studies were included
in the regression analysis.
Three main analyses were conducted:
(1) a meta-analysis of intervention effects on medication adherence;
(2) a series of univariable meta-regression analyses, regressing intervention ES across studies on
each of the eight BCTs (present vs. absent), number of BCTs used in the intervention, main deliv-
ery mode (SMS vs. IVR), additional delivery mode (present vs. absent), intervention duration (short
vs. long), direction of communication (two-way vs. one-way), and message frequency (more fre-
quent vs. less frequent); and
(3) a multivariable meta-regression analysis, regressing intervention ES on the eight BCTs (present vs.
absent).
A random effects model was used for the meta-analysis because it allows for different true ESs across
studies. The Q test was used to assess heterogeneity, with a signiﬁcant result (p < .05) taken as indi-
cating heterogeneity across studies. The I-squared statistic was computed to describe the percentage
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of the variability in effect estimates that is due to heterogeneity rather than sampling error (Higgins
et al., 2003). Following Higgins et al. (2003), I-squared values of 25%, 50% and 75%were considered to
indicate low, moderate, and high heterogeneity.
Possible publication bias was assessed by the funnel plot and Egger’s test (Egger, Smith, & Minder,
1997). Primary data were entered in the Comprehensive Meta-Analysis software (Borenstein, Hedges,
Higgins, & Rothstein, 2014), where a database to calculate ESs was created and all the statistical ana-
lyses were performed. Statistical significance was set at p < .05.
Results
Description of included studies
The search method identified 1410 records, of which 124 were assessed in full text. Seventeen studies
met the inclusion criteria (see supplementary material 2, for a list of studies excluded at this stage).
The PRISMA flow chart showing the selection process is provided in Figure 1.
In total the 17 studies randomised 38,671 participants to the intervention (n = 23,352) or com-
parator groups (n = 15,319), of whom 25,037 (65%) completed the measurements at follow-up.
Study participants’ mean age was 56.7 years, ranging from 47.5 to 76, and almost half of them
were female. Participants were recruited from primary care (k = 7), secondary care (k = 7), and
pharmacy (k = 3) settings. The targeted health conditions included coronary heart disease (k = 4),
type 2 diabetes mellitus (k = 3), high blood pressure (k = 3), high cholesterol (k = 3), comorbidities
of type 2 diabetes mellitus and cardiovascular conditions (k = 2), comorbidities of high blood pressure
and high cholesterol (k = 1), and stroke (k = 1). All studies involved prescriptions of complex medi-
cation regimens. Regarding the delivery mode, nine studies used SMS and eight used IVR. Nine
studies were conducted in the USA; two in Canada; and one in each of Malaysia, the Netherlands,
Pakistan, South Africa, Spain, and the UK. The characteristics of the included studies are reported
in Table 1.
Self-report questionnaires were the most common method of measuring medication adherence
(k = 12), followed by electronic pharmacy records (k = 5), electronic monitoring devices (k = 2), and
pill counts (k = 1). Two studies combined self-report questionnaires with electronic monitoring
devices, and one study combined self-report questionnaires with electronic pharmacy records.
Figure 1. Review flow chart.
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Table 1. Characteristics of included studies.
Author, year, country,
design
Characteristics of recruited participants and
recruitment methods
Health condition and
delivery mode
Frequency, schedule, duration, direction and language
of the intervention communication, and description of
the additional delivery mode and the comparator
group
Mediation adherence outcome
measures
Arora, Peters, Burner,
Lam, and Menchine,
2014, USA, RCT
Participants: I = 60% female, I = 50.5 (10.3) years.
C = 69% female, C = 51.0 (10.2) years.
Recruitment: Hospital, emergency department.
Identified from Emergency Department
Software and approached by a research
assistant during daytime hours
Type 2 diabetes mellitus
SMS
Frequency: 3 times per week for a period of 6 months
(plus 1 per day motivational/2 per week healthy
living/2 per week trivia). Schedule: At 9 am and at 5
pm. Duration: Max. 160 characters. Direction: One-
way. Language: English or Spanish.
vs. UC: Uncl.
SR* (Morisky 8 items) at 6 months
Bobrow, van Dijk
et al., 2016, South
Africa, RCT
Participants: I: 72% female, 54.05 (11.3) years.
C = 72% female, I = 54.7(11.6) years.
Recruitment: Outpatient chronic disease service
in a single public-sector clinic. Identified by
clinical staff during patients’ visits at clinic for
clinical reviews. Invited to the trial by a
research assistant
High blood pressure
SMS
Frequency: Weekly for a period of 1 year. Schedule:
Selected by participants. Duration: Max. 160
characters. Direction: One way and/or two way.
Language: Participants selected between English,
isiXhosa, and Afrikaans.
vs. UC: Welcome text, ‘happy birthday’ text and non-
health-related texts at 6-weekly intervals
ER (PDC)*; SR (Morisky) at 12 months
Derose et al., 2013,
USA, RCT
Participants: I = 51.0% female, I = 55.9 (12.4)
years. C = 50.1% female, C = 56.2 (12.5) years.
Recruitment: Pharmacy. Identified from
electronic records of health plan. Approached
and invited by an IVR call
High cholesterol
IVR
Frequency: 1 time for a period of 25 days. Schedule: At
1–2 weeks after the prescription date, between 10
am and 8 pm. Duration: Approximately 40 seconds.
Direction: One way. Language: English or Spanish.
Additional delivery mode: Letter sent 1 week after the
initiation of calls to participants who had not filled
their prescription.
vs. UC: Uncl.
ER* at 25 days
Gatwood et al., 2016,
USA, RCT
Participants: I = 50.0% female, I = 47.54 (12.1)
years. C = 50.0% female, C = 46.38 (11.57)
years.
Recruitment: Primary care health system.
Identified from electronic health record
system, invited by mail or face to face at a local
diabetes health fair
Type 2 diabetes mellitus
SMS
Frequency: 1 time per day for a period of 90 days.
Schedule: At the time of day coinciding with the
subject’s first dose. Duration: Assume max. 160
characters. Direction: One way. Language: English.
vs. UC: Usual care with monthly check-in messages
ER* (PDC) at 180 days
Guthrie, 2001, USA, RCT Participants: I = 50.8% female, I = 57.9 years. C =
52.4% female, C = 58.3 years.
Recruitment: Community, 90% in primary care.
Identified by a physician, who screened
participants for eligibility (using assessment
test for risk of first heart attack) and invited
them to the trial
High cholesterol
(at risk for first
myocardial infarction)
IVR
Frequency: 2 times for a period of 6 months. Schedule:
At 2 and 8 weeks after randomisation. Duration:
Uncl. Direction: One way. Language: English.
vs. UC: Face to face with physician at baseline and
reminder postcards at 4 and 5 months after
randomisation
SR* (taking meds as prescribed) at 6
months
Kamal et al., 2015,
Pakistan, RCT
Participants: I = 36% female, I = 56.07 (1.5) years.
C = 29% female, C = 57.62 (1.3) years.
Recruitment: Hospital, Neurology and Stroke
Stroke
SMS
Frequency: Up to 3 times per day (and 2 per week with
health information) for a period of 2 months.
Schedule: Daily messages around time to take
medication (and weekly messages usually
SR* (Morisky 8 items) at 2 months
(Continued )
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Table 1. Continued.
Author, year, country,
design
Characteristics of recruited participants and
recruitment methods
Health condition and
delivery mode
Frequency, schedule, duration, direction and language
of the intervention communication, and description of
the additional delivery mode and the comparator
group
Mediation adherence outcome
measures
clinics. Identified via records and recruited
during daily and annual clinic visits
at 5 pm). Duration: Assume max. 160 characters.
Direction: Two way. Language: English, Nastaleeq
Urdu (local Urdu script) or Roman Urdu.
vs. UC: Regular follow-up visits with their stroke
neurologists; provided with phone number to call in
case of emergency; and sms or phone reminders to
attend clinic appointments
Khonsari et al., 2015,
Malaysia, RCT
Participants: I = 12.9% female, I = 56 (11.3) years.
C = 16.1% female, C = 59 (13.9) years.
Recruitment: Hospital. Recruited prior to
discharge from cardiology ward after
admission for acute coronary syndrome.
Acute Coronary
Syndrome
SMS
Frequency: At least 1 time per day for a period of 2
months. Schedule: Before every intake of
medications and refill medications. Duration:
Assume max. 160 characters. Direction: One-way.
Language: Uncl.
vs. UC: Cardiac rehabilitation and follow up
appointment with cardiologist
SR* (Morisky 8 items) at 2 months
Marquez Contreras
et al., 2004, Spain,
Cluster RCT
Participants: I = 47.1% female, I = 56.26(10.22)
years. C = 42.4% female, C = 59.43(10.94)
years.
Recruitment: Urban and rural primary care.
Invited and recruited by a researcher
High Blood Pressure
SMS
Frequency: 2 times per week for a period of 6 months.
Schedule: Between at 11 am and 2 pm on randomly
chosen days from Monday to Friday. Duration: Max.
160 characters. Direction: One-way. Language:
Spanish.
Additional delivery mode: Printed information about
High Blood Pressure.
vs. UC: Face to face with physician at baseline and
follow up. Verbal and printed education information
PC by physician* at 6 months
Migneault et al., 2012,
USA, RCT
Participants: I = 65.7% female, I = 56.3(10.6)
years. C = 75.0% female, C = 56.8(11.4) years.
Recruitment: Primary care hospital and
community health centres. Identified by
searching electronic medical records, invited
by study staff via phone and recruited during
in-home visits
High Blood Pressure
IVR
Frequency: 11 times for a period of 8 months
(including introduction call, and additional 9 calls on
diet, and 12 calls for physical activity). Schedule:
Uncl. Duration: Uncl. Direction: Two way. Language:
English.
vs. UC: Attended an in-home visit trained research
assistant, received manual with (among other
things) information on hypertension and medication
taking, and 20-minute education based on content
of this manual
SR* (Morisky 7 items) at 8 months
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Park, Howie-Esquivel,
Chung, et al., 2014,
USA, RCT
Participants: I = 23.3% female, I = 58.2 (10.6)
years. C = 16.7% female, C = 61.1(9.1) years.
Recruited: Community hospital. Approached by
cardiologist or nurse
Coronary Heart Disease
SMS
Frequency: 86 times for a period of 30 days (74 daily
and 12 weekly). Schedule: The majority of messages
(n = 74) at times selected by participants that
correlated with medication schedule. The rest of the
messages (n = 12) on Monday, Wednesday and
Friday at 2pm. Duration: Assume max. 160
characters. Direction: Two way (for the n = 74) and
one-way for the n = 12. Language: English.
vs. UC: No text messages but otherwise Uncl.
SR (Morisky 8 items); EM* at 30 days
Piette, Weinberger, and
McPhee, 2000, USA,
RCT
Participants: I = 61% female, I = 56(10) years. C
= 56% female, C = 53(10) years.
Recruitment: General medicine clinics of a
county healthcare system. A research assistant
identified patients via medical records and
invited them during interviews
Type 2 Diabetes Mellitus
and Cardiovascular
Diseases
IVR
Frequency: An average of 1.4 times each month
(unclear how long the intervention lasted).
Schedule: Uncl. Duration: Uncl. Direction: Two way.
Language: English or Spanish.
Additional delivery mode: Follow up call by nurse, in
total 6-minute contact per month.
vs. UC: Resources available to patients upon request
SR* (3 items on reasons of
medication non-adherence) at 12
months
Sherrard et al., 2009,
Canada, RCT
Participants: I = 64.5(10.2) years. C = 62.4(11)
years. Total 27% female.
Recruitment: Hospital, heart institute. Recruited
at discharge
Coronary Heart Disease
(postoperative cardiac
surgery patients)
IVR
Frequency: 11 times for a period of 6 months.
Schedule: At 1, 2, 3, 4, 6,8, 10, 125, 16, 20, and 24
weeks after randomisation at a predetermined time.
Duration: Uncl. Direction: Two-way. Language:
English or French.
vs. UC: Usual standard, which included 1 IVR call on
day three and 10 after discharge to screen for
symptoms
SR* (remained or not on medication
prescribed on discharge from
hospital) at 6 months
Sherrard, Duchesne,
Wells, Kearns, and
Struthers, 2015,
Canada, RCT
Participants: I = 71.9% male, I = 62.3 (11.3) years.
C = 73.4% male, C = 63.6 (11.8) years.
Recruitment: Hospital. Recruited during hospital
visits
Acute Coronary
Syndrome
IVR
Frequency: 5 messages for a period of one year.
Schedule: At 1, 3, 6, 9 and 12 months after
randomisation, between 10 and 12 am, 3 and 5 pm,
or 6 and 8 pm. Duration: Uncl. (reports 5–8 min for
total duration of the call, including other than
medication adherence messages). Direction: Two
way. Language: English or French.
Additional delivery mode: Nurse phone call only when
the patient could not be reached by the system and
when system indicated that participant was no
longer taking medications.
vs. UC: Standard medical care: One call from cardiac
nurse at 1 year follow up to assess compliance with
best practice medication
SR* (remained or not on medication)
at 12 months
Stacy, Schwartz,
Ershoff, and Shreve,
2009, USA,
RCT
Participants: I = 62.1% female, I = 54.2 years. C =
62.7% female, C = 54.6 years.
Recruitment: Pharmacy. Identified from the
health plan pharmacy claims database.
Approached by an IVR call
High cholesterol
IVR
Frequency: Up to 2 times for the whole intervention
period (unclear how long the intervention lasted).
Schedule: At various times, including nights and
weekends. Duration: Uncl. Direction: Two-way.
Language: English.
ER* (MPR) at 6 months
(Continued )
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Table 1. Continued.
Author, year, country,
design
Characteristics of recruited participants and
recruitment methods
Health condition and
delivery mode
Frequency, schedule, duration, direction and language
of the intervention communication, and description of
the additional delivery mode and the comparator
group
Mediation adherence outcome
measures
Additional delivery mode: Web site for additional
information and print guide with tailored messages
(Uncl).
vs. UC: Single IVR giving non-tailored behaviour advice
and mailed guide on cholesterol
Vervloet, van Dijk et al.,
2012, the
Netherlands, RCT
Participants: I = 44.6% female, I = 54.9(6.6) years.
C = 45.8% female, C = 54.6(6.9) years.
Recruitment: Pharmacy. Pharmacy staff
identified participants via electronic records
and invited them in the study
Type 2 Diabetes Mellitus
SMS
Participants received their medication in a dispenser
that sent a message to a central server each time it
was opened.
Frequency: 1 each time the medication was not taken
as prescribed for a period of 6 months. Schedule:
Around the time the medication was not taken.
Duration: Assume max. 160 characters. Direction:
One way. Language: Dutch.
vs. UC: Medication dispenser without SMS reminders
SR (taking meds); EM* (doses taken
within time window) at 6 months
Vollmer et al., 2014,
USA,
RCT
Participants: I = 46.5% female, I = 63.6(12.1)
years. C = 47.3% female, C = 63.6(12.2) years.
Recruitment: Identified in health plan electronic
medical records
Type 2 Diabetes Mellitus
and Cardiovascular
Diseases
IVR
Frequency: On average 3.7 call attempts for a period of
9.6 months. Schedule: Around the time the
medications were due or overdue for a refill.
Duration: 2–3 minutes. Direction: One-way.
Language: English.
vs. UC: Usual services (normal education and care
management)
ER* (modified PDC) at 10 months
Wald, Bestwick,
Raiman, Brendell,
and Wald, 2014, UK,
RCT
Participants: I = 45% female, I = 60 (54–68)
years. C = 46% female, C = 61 (49–69) years.
Recruitment: Primary care. Identified from lists of
primary care practices lists, sent SMS or
recruited face to face by researcher at clinics
when attending practice
High blood pressure or
high cholesterol
SMS
Frequency: 1 time per day for a period of 2 weeks,
then 1 alternate days for 2 weeks, and then 1 weekly
for the remaining 22 weeks. Schedule: Just after the
time they were advised to take their medications.
Duration: Assume max. 160 characters. Direction:
Two way. Language: English.
Additional delivery mode: Telephone call to follow up
to non-adherent participants.
vs. UC: Standard care
SR* (whether they had stopped
taking their medications on at
least 22 of the previous 28 days) or
ER (when SR not available) at 6
months
Note: Participants’ characteristics are presented as percentage, mean (±SD), and median (interquartile range). The messages were coded as daily when delivered more frequently (i.e., daily) or weekly/
monthly when received less frequently (i.e., once per week or per month). The messages were coded as two-way communication when participants could reply to IVR/SMS message to modify and/or
tailor elements of the intervention (e.g., change the schedule and language of the text messages). One-way communication was coded when participants could not reply to intervention messages or
when they could only respond to opt out from the intervention (e.g., by texting ‘stop’). When intervention included both two-way and one-way communication, we included in the analysis the
direction of the communication used for the medication adherence messages only; otherwise the most frequently used direction. I: intervention group; C: comparator group; SR: self-reported;
PC: pill count; ER: electronic records from pharmacy; PDC: percentage of days covered; MPR: medication possession ratio; EM: electronic monitoring devices; UC: usual care; Uncl.: unclear information
provided to make a judgement. With asterisk (*) are indicated the data included in the meta-analysis.
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Twelve out of the 17 studies measured outcomes at least 6 months after randomisation. Fifteen out of
17 studies reported the duration of the intervention, with the average length being approximately 5.6
months (M = 169 days; range 25–360 days).
The number of BCTs used ranged from one to eight (median = 3). The most frequent BCT was
‘prompts and cues’, coded in 12 studies; followed by ‘personalised’ and ‘social support (unspecified)’
each coded in 8 studies; ‘tailored’ and ‘information about health consequences’ each coded in 7
studies; ‘habit formation’ and ‘report whether or not the behaviour was performed’ each coded in
5 studies; ‘problem solving’ coded in 3 studies’; ‘social support (practical)’ coded in 2 studies,
‘social reward’, ‘information about social and environmental consequences’, ‘adding objects to the
environment’, ‘self-talk’, ‘self-monitoring of behaviour’, ‘feedback on behaviour’, and ‘reduce
prompts/cues’, each coded in 1 study. No BCTs were coded for any of the following the taxonomy
clusters: shaping knowledge, comparison of behaviour, comparison of outcomes, regulation, identity,
scheduled consequences, and covert learning.
All studies reported the frequency of the intervention messages, with frequency ranging from
multiple messages per day to two messages per total intervention duration. Only a few studies
reported the duration of the IVR messages (e.g., 40 seconds), whereas for the SMS studies it was
assumed that each text was a maximum of 160 characters. In 6 out of 17 studies, there was an
additional delivery mode (i.e., additional to SMS/IVR) that was used in the intervention condition
but not in the comparator condition.
Nine studies compared the intervention to usual care, usually described as visits to a physician or
pharmacist without reporting detailed information on the content of the care provided. Four studies
described usual care as a minimal intervention (e.g., reminder postcards, medication dispenser, edu-
cational material). Four studies compared the intervention with a minimal intervention delivered by
IVR or SMS, but the latter did not include BCTs to support medication adherence (see Table 1).
Risk of bias arising from lack of blinding of participants or personnel was coded in all studies. Lack
of blinding of adherence outcome measurement was also coded in the majority of studies, due to the
use of self-report or lack of information on whether or not the assessor was blinded to allocation
group (for objective measurements). Ten out of 17 studies showed low attrition bias. Overall, 14 of
the 17 studies were assessed as having a high risk of bias (see Table 2).
Meta-analysis
On average, the interventions had a small but statistically significant effect on medication adherence,
OR = 1.89, 95% CI [1.51, 2.36], N = 25,101. Heterogeneity among studies was high and statistically sig-
nificant, Q = 143, p < .001, I2 = 88.8% (Figure 2).
The funnel plot (see Appendix 3) and statistically significant Egger’s test, p = .021, suggested poss-
ible publication bias, with relatively few of the less precise studies having ESs that fell below the
average ES. On the other hand, the fail-safe N was reassuringly large (735).
Meta-regression analysis
Univariable meta-regressions of intervention ES on each of the eight BCTs coded in at least three
studies, showed significant associations for only two BCTs: ‘information about health consequences’,
T2 = 0.04, R2 = 0.67, p = .006, and ‘reporting whether or not the behaviour was performed’, T2 = 0.11,
R2 = 0.21, p = .027. In both cases, the use of each BCT was associated with a larger intervention ES. The
number of BCTs included in the intervention was not significantly associated with ES. None of the
other intervention characteristics were associated with ES, although there was a marginally non-sig-
nificant tendency for two-way communication, T2 = 0.05, R2 = 0.62, p = .056, and higher message fre-
quency, T2 = 0.12, R2 = 0.11, p = .056, to be positively associated with larger intervention effects.
Multivariable meta-regression analysis showed that the presence or absence of the eight BCTs
together explained 88% of the variance in intervention ES. Moreover, the goodness-of-fit test was
HEALTH PSYCHOLOGY REVIEW 35
not statistically significant, T2 = 0.01, I2 = 30.7%, Q = 11.6, df = 8, p = .172, suggesting that the ES does
not vary across studies that use the same BCTs. The BCTs ‘tailored’ and ‘information about health con-
sequences’ were positively and significantly associated with a larger intervention ES, when the
remaining BCTs were controlled for. None of the other six BCTs were significantly associated with
intervention ES. However, there was a marginally non-significant association for ‘problem solving’,
with a negative coefficient showing that, controlling for other BCTs, interventions that used this
BCT tended to have smaller ESs (see Table 3).
Discussion
This systematic review and meta-analysis of 17 RCTs (N = 25,101) found that automated IVR or SMS
interventions on average almost double the odds (OR = 1.89) of adherence to cardio-metabolic medi-
cations compared with usual care. Taking into consideration the large reach and potential low cost of
the delivery modes (Orr & King, 2015; Smith et al., 2016), such interventions could have a significant
impact on public health if applied on a large scale. The present study also identified BCTs that are
positively associated with larger intervention ES: ‘tailored’, ‘information about health consequences’,
Table 2. Risk of bias.
Studies
Criteria
Random
sequence
generation
Allocation
concealment
Blinding of
participants and
personnel
Blinding of
outcome
assessment
Incomplete
outcome data
Selective
reporting
Other
bias
Arora et al.
(2014)
Low Uncl. High High High Uncl. Low
Bobrow et al.
(2016)
Low Low High Low Low low low
Derose et al.
(2013)
Low Uncl. High Low Low Uncl. Low
Gatwood et al.
(2016)
Low Uncl. High Low High Uncl. Low
Guthrie (2001) Uncl. Uncl. High High High Uncl. Low
Kamal et al.
(2015)
Low Low High High Low Low Low
Khonsari et al.
(2015)
Uncl. Uncl. High High Low Uncl. Low
Marquez
Contreras
et al. (2004)
Low Uncl. High High Low Uncl. Low
Migneault et al.
(2012)
Low Uncl. High High High Uncl. Low
Park, Howie-
Esquivel,
Chung, et al.
(2014)
Low Low High Low High Low Low
Piette et al.
(2000)
Low Low High High Low Uncl. Low
Sherrard et al.
(2009)
Uncl. Uncl. High High Low Uncl. Low
Sherrard et al.
(2015)
Low Low High High High Uncl. Low
Stacy et al.
(2009)
Uncl. Uncl. High Low Low Uncl. Low
Vervloet,
van Dijk et al.
(2012)
Uncl. Low High Low High High Low
Vollmer et al.
(2014)
Low High High Low Low Uncl. Low
Wald et al.
(2014)
Low Low High High Low High Low
Note: Low: low risk of bias; High: high risk of bias; Uncl.: unclear risk of bias.
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and ‘reporting whether or not the behaviour was performed’; although only the first two of these
were significant in the multivariable model. There was also a suggestion that two-way communi-
cation and more frequent messages (i.e., daily) may enhance effectiveness, but whether and how
these intervention characteristics impact on effectiveness need to be further investigated. The
number of BCTs, the main delivery mode, the additional delivery mode, and the intervention duration
were not associated with the intervention effectiveness.
Previous reviews recommended the potential of such platforms to deliver advice on adherence to
different types of prescribed medication (Mistry et al., 2015; Park, Howie-Esquivel, & Dracup, 2014).
However, to our knowledge this is the first systematic review with meta-analysis that has com-
prehensively investigated the effectiveness of IVR or SMS interventions to promote adherence to
cardio-metabolic medications. This review not only showed that such interventions are effective in
promoting adherence among participants who have been prescribed complex medication regimens,
but also identified BCTs that are associated with their effectiveness. Given the lack of evidence on
effective methods to promote medication adherence, reported by previous reviews (Mistry et al.,
2015; Nieuwlaat et al., 2014), these findings are a valuable contribution to our knowledge and
could inform recommendations for future interventions.
The results of this review suggest that interventions should be tailored, provide information about
the health consequences of adhering (or not) to prescribed medications, and ask participants to
Figure 2. Meta-analysis forest plot.
Table 3. Multivariable meta-regression analysis regressing intervention ES on all eight behaviour change techniques.
BCTs Β SE 95% CI Z p VIF
Intercept 0.178 0.465 [−0.734, 1.090] 0.38 .702 65.342
Tailored 1.100 0.417 [0.282, 1.917] 2.64 .008 7.615
Personalised −0.149 0.304 [−0.746, 0.447] −0.49 .622 6.879
Prompts/cues 0.039 0.447 [−0.837, 0.916] 0.09 .929 12.371
Habit formation −0.100 0.389 [−0.863, 0.662] −0.26 .795 3.937
Social support (unspecified) 0.097 0.349 [−0.587, 0.781] 0.28 .781 7.122
Information about health consequences 0.580 0.158 [0.270, 0.890] 3.67 .000 1.713
Problem solving −0.807 0.414 [−1.602, 0.006] −1.95 .051 5.133
Report whether or not the behaviour was performed 0.083 0.296 [−0.498, 0.664] 0.28 .779 4.251
Note: VIF: variance inflation factor; SE: standard error; CI: confidence intervals. Test of the model: Q= 35.10, df = 8, p< .001. Goodness
of fit: T2 = 0.016, T= 0.129, I2 = 30.73%, Q = 11.55, df = 8, p= .172. Total between-study variance: T2 = 0.138, T= 0.372, I2 = 88.78%,
Q= 142.56, df = 16, p< .001. Proportion of total between-study variance explained by model: R2 = 0.88.
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report whether or not they have taken their tablets as prescribed. This review did not investigate the
mechanisms by which these BCTs may increase adherence. However, we briefly outline some poss-
ible mechanisms based on existing findings and theories.
Tailoring, in which different messages are sent to different participants depending on infor-
mation obtained from or about them, was used in nine of the included studies. Automated IVR
and SMS systems are ideally suited to delivering tailored messages, including dynamic tailoring
in which messages are automatically modified using new or updated information obtained from
the user during the course of the intervention. However, the nature of the tailoring, including
the variables that were used to tailor the information, varied widely in the included studies. For
example, in Khonsari et al. (2015) text message reminders were simply tailored on medication
quantity (dose), medication name and time, as well as using the patient’s name (which we
coded as ‘personalised’). By contrast, the messages used by Gatwood et al. (2016) were tailored
according to participants’ responses to a series of theory-based questions on severity, susceptibility,
benefits, motivation, and other constructs (see Gatwood et al., 2014). There is substantial evidence
that tailored interventions are more effective than generic interventions (e.g., Hartmann-Boyce, Lan-
caster, & Stead, 2014). Tailored interventions may be seen by recipients as more personally relevant,
so they will be more likely to attend to, read, understand, and act on them. In addition, tailored
interventions are designed to change determinants of the target behaviour that are relevant to par-
ticular individuals (or to small subgroups of individuals); they therefore more precisely target the
determinants of the individual’s behaviour. There is scope for developing more highly tailored
interventions for medication adherence using IVR, SMS, and other digital platforms, although the
potential benefit of increased effectiveness has to be balanced against the increased burden of
measurement and greater complexity.
Providing information about health consequences, used in six of the included studied, may
address intentional non-adherence (Barber, 2002) or, more specifically, what Horne calls ‘necessity
beliefs’ (Horne et al., 2013). Some patients may have doubts about the effectiveness of their medi-
cation, and providing information about the health consequences (either the benefits of adherence
or the disbenefits of non-adherence) may help to assuage these doubts.
Such techniques may be more or less effective depending on the presence of other factors, which
Peters, de Bruin, and Crutzen (2015) refer to as ‘parameters of effectiveness’. For example, to the
extent that presenting the disbenefits of non-adherence arouses concern among non-adherent
patients, such information may be more effective if the recipients are already high on self-efficacy
and perceived response efficacy or if the intervention messages include efficacy statements (Tannen-
baum et al., 2015).
Used as a technique for changing behaviour, asking participants to report whether or not they
have taken their tablets may work partly through fear of social disapproval or desire for social
approval, even when they are reporting their behaviour to an automated system rather than directly
to another person. Of course, participants may overstate the extent of their adherence, that is, their
reports may not be valid. Nevertheless, knowing that they will be asked to report their adherence may
increase their adherence. This effect and potential mechanisms are worthy of investigation in future
studies.
The most frequently coded BCT was ‘prompts/cues’. Reminding patients to take their medication
would be expected to be an effective technique because it directly addresses non-intentional non-
adherence. However, use of this BCT was not associated with larger intervention ESs. There are
many ways of operationalising reminders, and in some of the included studies this may not have
been done in an effective way. For example, intervention participants in Guthrie (2001) received
only two telephone reminders during the 5-month intervention period. Marquez Contreras et al.
(2004) sent two SMS reminder messages per week between 11 am and 2 pm on randomly chosen
weekdays. In neither study were the messages individually tailored. By contrast, Park, Howie-Esquivel,
Chung, et al. (2014) sent tailored SMS reminders twice a day at times selected by participants related
to their medication schedule (e.g., an antiplatelet reminder in the morning and a statin reminder in
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the evening) and asked them to confirm receipt, e.g., ‘John, take Plavix 75 mg at 9.00 AM. Respond
with 1’.
Although a range of BCTs were used in the included interventions, some techniques that have
been shown in other studies to be effective in promoting adherence, such as ‘implementation inten-
tions’ (Farmer et al., 2012), or ‘action planning’ in the BCT taxonomy, were not used in any of the
interventions studied here. One reason could be that the delivery modes of IVR and SMS may not
be suited to conveying these techniques. Nevertheless, intervention developers could consider
including such techniques in future IVR and SMS interventions to promote adherence. Like remin-
ders, implementation intention interventions may address non-intentional non-adherence but may
have a more sustained effect by effectively helping to create a new habit (Gollwitzer & Bargh,
2005).
The findings of this review may have been affected by publication bias, with small studies having
small effects perhaps being less likely to be published. Moreover, only studies published in the
English language were included, which may limit the generalisability of the results. However,
among the included studies eight interventions delivered messages in languages other than
English, suggesting that the results may apply to non-English-speaking populations. The targeted
population of this review had a mean age of 57 years and were prescribed complex medication regi-
mens, which highlights the potential effectiveness of such interventions to support adherence in
people with cardio-metabolic multi-morbidities (Di Angelantonio et al., 2015; WHO, 2016).
This review combined collecting and taking medications. Although this approach was used in pre-
vious reviews (e.g., Mistry et al., 2015), collecting a prescription from a pharmacy and taking tablets as
prescribed are distinct behaviour that may differ in important ways, including frequency and the role
of habit, and may require somewhat different interventions or BCTs. This distinction warrants inves-
tigation in future studies.
The majority of the studies included in this review used self-report measures of adherence,
which are likely to overestimate the true effect of adherence (a social desirability effect). This
would be a particular problem if there was differential bias, i.e., if overestimation was greater
in the intervention condition than in the comparator condition. However, the small number of
studies that used electronic monitoring devices to measure adherence also had positive ESs,
which supports the overall conclusions. It should be noted that objective measures of adherence
may also have limitations that need to be considered when interpreting the findings; for example,
electronic monitoring may have a reactive effect on behaviour (Sutton et al., 2014).
Similar to previous studies (e.g., Peters et al., 2015), this review used a multivariable meta-
regression model that included several BCTs. However, even though the model could explain a con-
siderable amount of the observed heterogeneity, the variance inflation factor was rather high for
most of the BCTs, meaning that they are correlated with each other, and that it is therefore difficult
to estimate their independent effects. There may also be study-level characteristics relating to partici-
pants, setting, intervention, design, or measures that may partly explain the associations observed
between the BCTs and the intervention ES or mask true associations (Peters et al., 2015). Examples
of possible confounding factors include the socioeconomic status of the participants, follow-up
period, and study quality indicators.
In this review, we were unable to code the BCTs used in the comparator groups, due to
limited information included in the studies. In similar way to the intervention group, variation
in the comparator groups, such as the content, frequency, and duration of information relevant
to medication adherence could have influenced the findings of this review (De Bruin, Viecht-
bauer, Hospers, Schaalma, & Kok, 2009; Peters et al., 2015). Thus, it would be helpful if future
studies provided a full description of the comparator interventions to enable meta-regressions
to focus on the differences between the BCTs used in the intervention and comparator
conditions.
In conclusion, the findings of this review suggest that automated IVR and SMS interventions can
increase medication adherence but highlight the need for intervention studies with better quality
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designs and objective outcome measures. Future research could also investigate the mechanisms by
which the identified BCTs may increase adherence (Kassavou & Sutton, 2017). Moreover, future inter-
vention studies could usefully explore the effect of additional techniques (e.g., ‘implementation
intentions’) to promote objectively measured medication adherence.
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